Jasper Ridge Partners’s Histogen Inc. Common Stock HSTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-78
Closed -$86K 81
2017
Q3
$86K Hold
78
﹤0.01% 78
2017
Q2
$90K Hold
78
﹤0.01% 83
2017
Q1
$90K Sell
78
-159
-67% -$153K 0.01% 92
2016
Q4
$250K Buy
+237
New +$108K 0.02% 88
2015
Q4
Sell
-107
Closed -$95K 95
2015
Q3
$95K Hold
107
0.01% 83
2015
Q2
$110K Hold
107
0.01% 90
2015
Q1
$152K Hold
107
0.01% 88
2014
Q4
$149K Sell
107
-116
-52% -$168K 0.01% 80
2014
Q3
$273K Sell
223
-97
-30% -$139K 0.02% 101
2014
Q2
$583K Hold
320
0.04% 86
2014
Q1
$521K Buy
+320
New +$669K 0.03% 87

Other funds holding HSTO

Jasper Ridge Partners's HSTO Position: Q4 2017 in Review

Jasper Ridge Partners sold out of Histogen Inc. Common Stock (HSTO) in Q4 2017, closing a stake of 78 shares — an estimated $86K sold.

Jasper Ridge Partners first reported a position in HSTO in Q1 2014 and held it in 11 quarters. The position peaked at $583K in Q2 2014. 70 funds tracked by Wall St. Rank hold HSTO as of Q4 2017.

  • Jasper Ridge Partners reported no remaining Histogen Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Jasper Ridge Partners sold 78 Histogen Inc. Common Stock shares in Q4 2017, an estimated $86K.
  • Jasper Ridge Partners first reported a position in Histogen Inc. Common Stock in Q1 2014 and held it in 11 quarters.
  • Jasper Ridge Partners's Histogen Inc. Common Stock position peaked at $583K in Q2 2014.
  • 70 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q4 2017.

Based on Jasper Ridge Partners's 13F filing for Q4 2017, filed 14 Feb 2018.